Difficulty: Medium
Average Score: 78%
Practice
Patients who are being treated with epoetin alfa need to be monitored for the development of:
Correct answer
C
Rationale
In the context of hematological drugs, such as epoetin alfa, it is crucial for healthcare providers to monitor patients for potential adverse effects to ensure optimal treatment outcomes. The correct answer, option C) Hypertension, is the most pertinent side effect associated with epoetin alfa therapy. Epoetin alfa is a medication used to stimulate red blood cell production in conditions like anemia, often seen in patients with chronic kidney disease or undergoing chemotherapy.
Patients on epoetin alfa therapy are at an increased risk of developing hypertension due to the medication's effect on increasing red blood cell production. The rise in red blood cells can lead to increased blood viscosity and, subsequently, hypertension. Monitoring blood pressure regularly during treatment is essential to detect and manage hypertension promptly.
Options A) Thrombocytopenia and B) Neutropenia are less likely to be associated with epoetin alfa therapy. Thrombocytopenia refers to low platelet count, which is not a common side effect of epoetin alfa. Neutropenia, a low white blood cell count, is also not a typical concern with this medication. Option D) Gout is not directly linked to epoetin alfa therapy either.
In an educational context, understanding the side effects and monitoring requirements of hematological drugs like epoetin alfa is crucial for healthcare professionals to provide safe and effective care to their patients. By knowing the expected side effects and appropriate monitoring protocols, healthcare providers can intervene early, prevent complications, and ensure the best possible treatment outcomes for patients receiving these medications.
Patients on epoetin alfa therapy are at an increased risk of developing hypertension due to the medication's effect on increasing red blood cell production. The rise in red blood cells can lead to increased blood viscosity and, subsequently, hypertension. Monitoring blood pressure regularly during treatment is essential to detect and manage hypertension promptly.
Options A) Thrombocytopenia and B) Neutropenia are less likely to be associated with epoetin alfa therapy. Thrombocytopenia refers to low platelet count, which is not a common side effect of epoetin alfa. Neutropenia, a low white blood cell count, is also not a typical concern with this medication. Option D) Gout is not directly linked to epoetin alfa therapy either.
In an educational context, understanding the side effects and monitoring requirements of hematological drugs like epoetin alfa is crucial for healthcare professionals to provide safe and effective care to their patients. By knowing the expected side effects and appropriate monitoring protocols, healthcare providers can intervene early, prevent complications, and ensure the best possible treatment outcomes for patients receiving these medications.